Blog
RSS FeedPosted by Michael Wonder on 17 May 2022
The drugs that give her life cost more than half the family's income
18 May 2022 - For Vickie Hudson-Craig, this year’s Budget could mean the difference between life and death. ...
Posted by Michael Wonder on 28 Apr 2022
Cancer agency report duplicates PHARMAC role
28 April 2022 - The Cancer Control Agency’s analysis of the gap between Australia and New Zealand in funding 18 selected ...
Posted by Michael Wonder on 27 Apr 2022
PHARMAC welcomes analysis into cancer medicines in Aotearoa
28 April 2022 - PHARMAC welcomes a new report released today by Te Aho o Te Kahu (the Cancer Control ...
Posted by Michael Wonder on 16 Mar 2022
PHARMAC deal good news for New Zealanders
16 March 2022 - The Government is welcoming news the national drug-funding agency PHARMAC has secured an agreement for medicines ...
Posted by Michael Wonder on 16 Mar 2022
PHARMAC to fund new treatments for lung and ovarian cancer
16 March 2022 - PHARMAC has confirmed today they are funding a bundle deal which will give New Zealanders more ...
Posted by Michael Wonder on 26 Jan 2022
Former bowel cancer patient calls for NZ to fund drug she says saved her life
26 January 2022 - A woman with bowel cancer who was told she may have two years to live says ...
Posted by Michael Wonder on 16 Dec 2021
PHARMAC looking to fund medicines for lung and ovarian cancer
16 December 2021 - PHARMAC is considering funding a bundle deal which would give New Zealanders more effective treatment options for ...
Posted by Michael Wonder on 14 Dec 2021
PHARMAC still stalled on lung cancer drug
14 December 2021 - Lung cancer sufferers are still waiting on PHARMAC to reverse a decision made more than a ...
Posted by Michael Wonder on 08 Dec 2021
Funding Keytruda for melanoma but not for lung cancer is racist, health advocates say
8 December 2021 - PHARMAC has been accused of institutional racism and breaching the Treaty of Waitangi for funding drugs ...
Posted by Michael Wonder on 29 Jul 2021
Cancer patients, advocates 'gobsmacked' PHARMAC declining funding application for life-changing drug
29 July 2021 - Ovarian cancer patients and advocates are "utterly gobsmacked" Pharmac has proposed to decline a funding application ...
Posted by Michael Wonder on 19 Jul 2021
Decision to widen access to rituximab for people with B-cell acute lymphoblastic leukaemia/lymphoma
9 July 2021 - PHARMAC is widening access to rituximab (Riximyo) to include treatment of people with newly diagnosed B-cell ...
Posted by Michael Wonder on 14 Jul 2021
No more sending Kiwis across the ditch as new national neuroendocrine cancer treatment service opens
14 July 2021 - The opening of a new multimillion dollar national service to treat neuroendocrine cancer means patients will ...
Posted by Michael Wonder on 05 May 2021
'Intimidating' PHARMAC move may lead to child cancer drug delays
6 May 2021 - Two of New Zealand's leading cancer experts have slammed PHARMAC's proposal to take away the special exemption ...
Posted by Michael Wonder on 04 May 2021
New Zealand ‘falling behind’ in lung cancer treatment
4 May 2021 - New Zealand employs a third world approach to the detection, treatment and care of lung cancer, ...
Posted by Michael Wonder on 03 May 2021
PHARMAC likely to end blanket funding for kids’ cancer drugs
3 May 2021 - A woman trying to get drugs funded for young spinal muscular atrophy patients was horrified when PHARMAC ...